A previous study has revealed an inverse relationship between EGFR mutation and PD‐L1 expression,27 with EGFR mutations being associated with a lack of T cell infiltration and noninflammatory tumor microenvironment.28 These features may explain poor outcomes after starting immunotherapy for patients with EGFR mutations. This evidence concerns the gene EGFR and neoplasm.